Gene expression profiling to predict response to neoadjuvant docetaxel and capecitabine for breast cancer

被引:0
|
作者
Korde, L.
Zujewski, J.
McShane, L.
Lukes, L.
Lebowitz, P.
Swain, S.
Finney, R.
Hunter, K.
机构
[1] Natl Canc Inst, Bethesda, MD USA
[2] NCI, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:119 / 119
页数:1
相关论文
共 50 条
  • [1] Gene expression profiling to predict response to neoadjuvant docetaxel and capecitabine for breast cancer.
    Korde, L.
    Zujewski, J.
    McShane, L.
    Lukes, L.
    Lebowitz, P.
    Finney, R.
    Hunter, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S137 - S138
  • [2] Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
    Korde, Larissa A.
    Lusa, Lara
    McShane, Lisa
    Lebowitz, Peter F.
    Lukes, LuAnne
    Camphausen, Kevin
    Parker, Joel S.
    Swain, Sandra M.
    Hunter, Kent
    Zujewski, Jo Anne
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (03) : 685 - 699
  • [3] Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
    Larissa A. Korde
    Lara Lusa
    Lisa McShane
    Peter F. Lebowitz
    LuAnne Lukes
    Kevin Camphausen
    Joel S. Parker
    Sandra M. Swain
    Kent Hunter
    Jo Anne Zujewski
    Breast Cancer Research and Treatment, 2010, 119 : 685 - 699
  • [4] Prediction of docetaxel response in human breast cancer by gene expression profiling
    Iwao-Koizumi, K
    Matoba, R
    Ueno, N
    Kim, SJ
    Ando, A
    Miyoshi, Y
    Maeda, E
    Noguchi, S
    Kato, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) : 422 - 431
  • [5] Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
    Chang, JC
    Wooten, EC
    Tsimelzon, A
    Hilsenbeck, SG
    Gutierrez, MC
    Elledge, R
    Mohsin, S
    Osborne, CK
    Chamness, GC
    Allred, DC
    O'Connell, P
    LANCET, 2003, 362 (9381): : 362 - 369
  • [6] Gene expression profiling to predict chemotherapy response in primary breast cancer
    Schneeweiss, Andreas
    Lichter, Peter
    Sohn, Christof
    Hahn, Meinhard
    BREAST CARE, 2006, 1 (06) : 362 - 367
  • [7] Gene expression profiling involved in response to neoadjuvant therapy in breast cancer.
    Bofill, Salvador
    Garrigos, Carmen
    Benavent, Marta
    Gonzalez, Rosario
    Montano, Alvaro
    Falcon Gonzalez, Alejandro
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Breast cancer gene expression profiles predict response to neoadjuvant taxotere.
    Wooten, EC
    Hilsenbeck, SG
    Tsimelzon, A
    Mohsin, S
    Gutierrez, C
    Chang, J
    O'Connell, P
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S65 - S65
  • [9] Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients
    Chang, JC
    Wooten, EC
    Tsimelzon, A
    Hilsenbeck, SG
    Gutierrez, MC
    Tham, YL
    Kalidas, M
    Elledge, R
    Mohsin, S
    Osborne, CK
    Chamness, GC
    Allred, DC
    Lewis, MT
    Wong, H
    O'Connell, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1169 - 1177
  • [10] Prediction of the therapeutic response to paclitaxel by gene expression profiling in neoadjuvant chemotherapy for breast cancer
    Yoshimoto, M
    Makita, M
    Nishimura, S
    Tada, K
    Kasumi, F
    Akiyama, F
    Hoshikawa, Y
    Miki, Y
    Matsuura, M
    Noda, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 3S - 3S